Nuo Therapeutics Inc. has entered into a new Loan and Security Agreement with four lenders, providing for loans totaling up to $1.6 million. The agreement includes an initial funding of $1.0 million, which closed on January 23, 2026, and a potential second funding of $600,000 available on September 30, 2026, subject to certain conditions. The loans are secured by a lien on all of the company's assets, including its intellectual property. Nuo Therapeutics plans to use the proceeds for general working capital purposes. As part of the deal, the company also issued warrants to the lenders to purchase shares of its common stock, with additional warrants to be issued as payment for accrued interest. Notably, two of the lenders are significant shareholders and insiders of the company.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-002078), on January 26, 2026, and is solely responsible for the information contained therein.